Efficacy and cognitive impact of modified Atkins diet in adults with drug-resistant epilepsy
Brain & Heart · 2024
DOI: 10.36922/bh.1978 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain & Heart, 2024. Verfasst von Huixin Liu und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This study aims to explore the efficacy and cognitive impact of the modified Atkins diet (MAD) in adults with drug-resistant epilepsy, as well as to analyze changes in epileptiform activity during ketogenic diet (KD) intervention. We performed a prospective, open-label study with patients aged 16 – 60 years who met the International League Against Epilepsy (ILAE) criteria for drug-resistant epilepsy. Sixteen patients were enrolled in this study, and baseline clinical and electroencephalography (EEG) characteristics, along with neuropsychological tests, were collected before and after 3 months of KD. Patients were divided into responders (≥50% seizure reduction) and non-responders (
Zitieren
APA
Liu, H., Lu, H., Ji, Y., Liu, W., Yang, H., Zhang, X., Li, J., & Sun, W. (2024). Efficacy and cognitive impact of modified Atkins diet in adults with drug-resistant epilepsy. Brain & Heart. https://doi.org/10.36922/bh.1978
Vancouver
Liu H, Lu H, Ji Y, Liu W, Yang H, Zhang X, et al. Efficacy and cognitive impact of modified Atkins diet in adults with drug-resistant epilepsy. Brain & Heart. 2024. doi:10.36922/bh.1978
BibTeX
@article{Liu2024,
author = {Liu, Huixin and Lu, Hongjuan and Ji, Yichen and Liu, Wenjian and Yang, Haoran and Zhang, Xuan and Li, Jiayi and Sun, Wei},
title = {Efficacy and cognitive impact of modified Atkins diet in adults with drug-resistant epilepsy},
journal = {Brain & Heart},
year = {2024},
doi = {10.36922/bh.1978}
}
EUVIMED